PanoramicaGraficoNotizieSchermataTrader

Oragenics Inc/  US6840235005  /

IEX
08/11/2024  21:56:43 Var. +0.07 Volume Denaro- Lettera- Max Min
0.38USD +21.78% 4,590
Fatturato: 1,734.44		 -Quantità in denaro: - -Quantità in lettera: - 0.40 0.34
GlobeNewswire 21/08 Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation ...
GlobeNewswire 16/08 Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYS...
GlobeNewswire 14/08 Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wid...
GlobeNewswire 12/08 Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study
GlobeNewswire 08/08 Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity T...
GlobeNewswire 10/07 Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients
GlobeNewswire 27/06 Oragenics Develops Automated Intranasal Device for Treating Concussed Patients
GlobeNewswire 26/06 Oragenics, Inc. Announces Closing of Public Offering
GlobeNewswire 25/06 Oragenics, Inc. Announces Pricing of Public Offering
GlobeNewswire 25/06 Oragenics, Inc. Announces Proposed Public Offering
GlobeNewswire 20/06 Oragenics, Inc. Announces NYSE American Acceptance of Plan of Compliance
GlobeNewswire 22/05 Oragenics Appoints William “Frank” Peacock MD as Chief Clinical Officer
GlobeNewswire 17/05 Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine
GlobeNewswire 16/05 Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial
GlobeNewswire 07/05 Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia
GlobeNewswire 01/09/2020 Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent Developm...
GlobeNewswire 14/07/2020 Recce Pharmaceuticals Adds Biotech Veteran Alan W. Dunton M.D. to its Board of Directors
GlobeNewswire 30/04/2019 Investor Expectations to Drive Momentum within H&R Block, Aercap Holdings N.V, Oragenics, and Atomer...
GlobeNewswire 20/06/2018 Diamond Equity Research Initiates Coverage on Oragenics Inc. (NYSE:OGEN) with a Valuation of $3.50 P...
GlobeNewswire 16/05/2018 Oral Proteins and Peptides Market, 2030
GlobeNewswire 29/06/2017 Rocky Mountain High Brands Announces Jerry Grisaffi’s Retirement; Gerry David Named Chairman of the ...
GlobeNewswire 25/04/2017 Rocky Mountain High Brands Appoints Award Winning CEO, Gerry David, to Its Board of Directors and Sp...